BackErasca Overview

Erasca Current Cash

Erasca's current cash is $43M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$42.54M
35.68% YoYΔ $-23.60M vs prior year quarter

Peer trimmed avg / median

Loading

Erasca Current Cash History

Loading

Erasca vs. peers: Current Cash Comparison

Loading

Erasca Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Erasca (ERAS) FAQ

As of the most recent data (June 2026), ERAS shows a current cash of $43M. That compares with $66M in the prior-year period — down 35.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ERAS's current cash is now $43M (was $66M) — a 35.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Erasca is outperforming or lagging.

Tracking ERAS's current cash over time shows whether Erasca is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $66M in the prior-year period — down 35.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Erasca's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $43M) with ownership activity and broader fundamentals.

Erasca's current cash is $43M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.